Research Article
Comparative Study on the Efficacy and Safety of Tumor Resection in Vitrectomy for Retinal Vasoproliferative Tumors
Table 1
Summary of RVPT vitrectomy procedures.
| | | Article | Patient | Tumors | First treatment | Second treatment | Third treatment | | Author | Year | Country | Journal | Eyes | Age | BCVA pre (post) | Type | EndoR | Tumor | Vitrect | Tumor | Vitrect | Tumor | Vitrect |
| | 1 | Castro-N [17] | 2016 | USA | OmanJ Ophthalmol | 1 | 29 | 0.05 (0.4) | P | no | Cryo | no | no | SEMM | | | | 2 | Garcia [6] | 2015 | Spain | Ophthalmic Research | 31 | 37.8 (12.7–65.6) | 0.46 (?) | P/S = 23/8 (PP × 5; RP × 2; Tp × 1) | no | 17 (Ph + Cryo × 6; Ph × 17; Cryo × 8) | 17 (EMM × 10; RRD × 2; VH × 2; TRD × 1; SRD × 1; SHH × 1) | 11 (Ph + Cryo × 2; Ph × 6; Cryo × 1; Ru × 1; TTT × 1) | 8 (EMM × 5; RRD × 1; MH × 1;VH × 1) | 3 (Ph × 2 + 1) | 2 (EMM × 2) | | 3 | Nakamura [18] | 2013 | Japan | Retinal Cases Brief Reports | 1 | 78 | 0.5 (0.03) | Unclear | yes | no | RT + NVG | | | | | | 4 | Saito [19] | 2013 | Japan | Retina | 1 | 54 | 0.5 (1.2) | S (Coats) | yes | IVB | RT + RRD | | RRRD | | | | 5 | Makdoumi [8] | 2011 | Sweden | Acta Ophthalmol | 8 | 36 | 0.0 6 (0.1) | S (Asteroid hyalosis | no | Cryo + Ph | EMM | Cryo | CE | | | | 66 | 0.3 (0.3) | P | no | Cryo | | | EMM + CE | | | | 74 | 0.1 (0.2) | P | no | Cryo | | Ph | EMM + CE | | | | 14 | 0.6 (1.0) | P | no | Ph | EMM | | | | | | 14 | 0.3 (0.6) | P | no | Cryo + Ph | EMM | | | | | | 60 | 0.1 (0.1) | S (chorioretinitis) | no | Cryo | EMM | Tr | | | | | 65 | 0.2 (0.4) | S (uveitis) | no | Cryo | EMM | | | | | | 62 | 0.4 (0.5) | P | no | Ph × 5 | | Cryo | EMM | | | | 6 | Steven [20] | 2010 | USA | Arch Ophthalmol | 1 | 31 | 0.4 (0.5) | Unclear | yes | no | RT + VH | | | | | | 7 | Gibran [16] | 2008 | USA | Clin Exp Ophthalmol | 3 | 20 | CF (0.3) | P | yes | Cryo + IVB + PDT | | | RT + EMM + CE | | SO removal | | 33 | 0.1 (0.2) | P | yes | Cryo + IVB | | | RT + EMM + CE | | IOL-e+(sfau) | | 27 | CF (0.15) | S (uveitis) | yes | Cryo + IVB | | | RT + CE | | IOL-e+(sfau) | | 8 | Youssef [14] | 2007 | USA | Reinal Cases Brief Reports | 1 | 39 | 0.05 (0.8) | Unclear | no | Cryo | | | SME | | | | 9 | Shankar [21] | 2007 | UK | Eye | 1 | 34 | 0.25 (unclear) | P | no | Cryo | no | Cryo | EMM | | | | 10 | Liang [22] | 2007 | China | Ophthalmology | 1 | 17 | 0.6 (0.9) | P | yes | no | RT | | | | |
|
|
CE = cataract extraction; Cryo = cryotherapy; EMM = epimacular membrane; EndoR = endoresection; IOL = intraocular lens; IOL-E+ = IOL explanation + SO removal + artisan IOL insertion; MH = macular hole; NVG = neovascular glaucoma; IVB = intravitreal bevacizumab; PDT = photodynamic therapy; PP = pars planitis: Ph = photocoagulation; RP = retinitis pigmentosa; Ru = ruthenium plaque; RRD = rhegmatogenous retinal detachment; RRRD = recurrent RRD; RT = resected tumor; SFAU = severe fibrinous anterior uveitis; SRD = serous retinal detachment; SHH = subhyaloid hemorrhage; SME = submacular exudates: SO = silicon oil; Tp = toxoplasmosis; TRD = tractional retinal detachment; TTT = transpupillary thermotherapy; Tr = triamcinolon; VH = vitreous hemorrhage; Vitrect = vitrectomy.
|
